BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8890566)

  • 1. [Molecular basis and pathophysiology of red cell enzymopathies].
    Kanno H
    Nihon Rinsho; 1996 Sep; 54(9):2382-9. PubMed ID: 8890566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity.
    Aizawa S; Harada T; Kanbe E; Tsuboi I; Aisaki K; Fujii H; Kanno H
    Exp Hematol; 2005 Nov; 33(11):1292-8. PubMed ID: 16263413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes.
    Miwa S; Fujii H
    Am J Hematol; 1996 Feb; 51(2):122-32. PubMed ID: 8579052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary structure of murine red blood cell-type pyruvate kinase (PK) and molecular characterization of PK deficiency identified in the CBA strain.
    Kanno H; Morimoto M; Fujii H; Tsujimura T; Asai H; Noguchi T; Kitamura Y; Miwa S
    Blood; 1995 Oct; 86(8):3205-10. PubMed ID: 7579416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell enzymopathies as a model of inborn errors of metabolism.
    Miwa S; Kanno H; Hirono A; Fujii H
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():112-9. PubMed ID: 8629088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK.
    van Wijk R; Huizinga EG; van Wesel AC; van Oirschot BA; Hadders MA; van Solinge WW
    Hum Mutat; 2009 Mar; 30(3):446-53. PubMed ID: 19085939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of red cell enzymopathies associated with hereditary nonspherocytic hemolytic anemia.
    Miwa S
    Haematologia (Budap); 1989; 22(4):215-31. PubMed ID: 2560452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate kinase deficiency of mice associated with nonspherocytic hemolytic anemia and cure of the anemia by marrow transplantation without host irradiation.
    Morimoto M; Kanno H; Asai H; Tsujimura T; Fujii H; Moriyama Y; Kasugai T; Hirono A; Ohba Y; Miwa S; Kitamura Y
    Blood; 1995 Dec; 86(11):4323-30. PubMed ID: 7492793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of canine pyruvate kinase deficiency.
    Whitney KM; Goodman SA; Bailey EM; Lothrop CD
    Exp Hematol; 1994 Aug; 22(9):866-74. PubMed ID: 7520391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology and laboratory tests of hemolytic anemia: with special reference to erythroenzymopathies].
    Fujii H; Miwa S
    Rinsho Byori; 1989 Dec; 37(12):1331-43. PubMed ID: 2693773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyruvate kinase deficiency: correlation between enzyme activity, extent of hemolytic anemia and protection against malaria in independent mouse mutants.
    Min-Oo G; Tam M; Stevenson MM; Gros P
    Blood Cells Mol Dis; 2007; 39(1):63-9. PubMed ID: 17466543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic rescue of hemolytic anemia due to red blood cell pyruvate kinase deficiency.
    Kanno H; Utsugisawa T; Aizawa S; Koizumi T; Aisaki K; Hamada T; Ogura H; Fujii H
    Haematologica; 2007 Jun; 92(6):731-7. PubMed ID: 17550844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pyruvate kinase (PK) isozyme switching and genetic heterogeneity of PK deficiency].
    Kanno H
    Nihon Rinsho; 1995 May; 53(5):1213-20. PubMed ID: 7602781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic expression of pyruvate kinase deficiency and protection against malaria in a mouse model.
    Min-Oo G; Fortin A; Tam MF; Gros P; Stevenson MM
    Genes Immun; 2004 May; 5(3):168-75. PubMed ID: 15029238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.
    Lakomek M; Winkler H; Pekrun A; Krüger N; Sander M; Huppke P; Schröter W
    Enzyme Protein; 1994-1995; 48(3):149-63. PubMed ID: 8589802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of impaired pyruvate kinase isozyme conversion in erythroid cells: a single amino acid substitution near the active site and decreased mRNA content of the R-type PK.
    Kanno H; Fujii H; Tsujino G; Miwa S
    Biochem Biophys Res Commun; 1993 Apr; 192(1):46-52. PubMed ID: 8476433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate kinase deficiency: the genotype-phenotype association.
    Zanella A; Fermo E; Bianchi P; Chiarelli LR; Valentini G
    Blood Rev; 2007 Jul; 21(4):217-31. PubMed ID: 17360088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-6-phosphate dehydrogenase and red cell pyruvate kinase deficiency in neonatal jaundice cases in egypt.
    Abdel Fattah M; Abdel Ghany E; Adel A; Mosallam D; Kamal S
    Pediatr Hematol Oncol; 2010 May; 27(4):262-71. PubMed ID: 20426517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell pyruvate kinase deficiency: molecular and clinical aspects.
    Zanella A; Fermo E; Bianchi P; Valentini G
    Br J Haematol; 2005 Jul; 130(1):11-25. PubMed ID: 15982340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare hereditary red blood cell enzymopathies associated with hemolytic anemia - pathophysiology, clinical aspects, and laboratory diagnosis.
    Koralkova P; van Solinge WW; van Wijk R
    Int J Lab Hematol; 2014 Jun; 36(3):388-97. PubMed ID: 24750686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.